Say hello to
new Qelbree!

pink divider

Introducing new FDA-approved
Qelbree, used to treat
attention-deficit/hyperactivity
disorder (ADHD) in children
ages 6 to 17.

Focus is just the beginning. There is peace of mind in knowing a safe, effective approach to multi-symptom ADHD control can conveniently fit into you and your child’s schedule with one simple dose.

Qelbree Copay Card

Sign up to save on your Qelbree prescription

it's easy to sign up and elegible patients may pay as little as $20 per prescription


Sign up icon

Let’s keep in touch – sign up for updates

Get notified when Qelbree becomes available, plus tap into exclusive info on savings, updates and more.

Sign up icon

You’re in!

Next, check your inbox for a confirmation email.

We’re here to
support you

Have questions? Find a single point of contact with Supernus Support and get help with any of the following:

  • Ways to save on Qelbree
  • Medication access
  • Insurance coverage for Qelbree

Reach us anytime Monday - Friday, 8:30 AM - 6:30 PM ET (excluding holidays): 1-866-398-0833

SPN Consumer Support

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

Suicidal thoughts and behaviors:

  • Qelbree may increase suicidal thoughts and actions [read more] in some children with ADHD, especially within the first few months of treatment or when the dose is changed.
  • Help prevent suicidal thoughts and actions in your child or adolescent by paying close attention to any new or sudden changes in mood, behavior, thoughts, and feelings. Call your child’s doctor right away or get emergency help if there are any new or sudden changes (e.g., attempts to commit suicide, depression, agitation or restlessness, insomnia, acting aggressive, angry or violent, an extreme increase in activity and talking, thoughts about suicide or dying, anxiety, panic attacks, irritability, acting on dangerous impulses, and other unusual changes in behavior or mood).
  • Qelbree may increase suicidal thoughts and actions in some children with ADHD, especially within the first few months of treatment or when the dose is changed. [read more]
  • Help prevent suicidal thoughts and actions in your child or adolescent by paying close attention to any new or sudden changes in mood, behavior, thoughts, and feelings. Call your child’s doctor right away or get emergency help if there are any new or sudden changes (e.g., attempts to commit suicide, depression, agitation or restlessness, insomnia, acting aggressive, angry or violent, an extreme increase in activity and talking, thoughts about suicide or dying, anxiety, panic attacks, irritability, acting on dangerous impulses, and other unusual changes in behavior or mood).

Your child should not take Qelbree if they: take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or stopped taking an MAOI in the last 14 days; or take alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, or theophylline.

Tell your child’s doctor about all your child’s medical conditions, such as: a personal or family history of suicide, bipolar disorder, depression, mania or hypomania, blood pressure or heart rate problems, severe kidney or liver problems

Before taking Qelbree, tell your doctor if your child is or plans to become pregnant or, is or plans to breastfeed. You and your child’s doctor will decide if your child should take Qelbree.

Tell your doctor about all medicines your child takes or recently has taken. Qelbree and other medicines may affect each other causing possible serious side effects. Do not start or stop any medicines while taking Qelbree without talking to your child’s doctor first.

Do not let your teen drive or operate heavy machinery until you know how Qelbree will affect them. Qelbree may cause your teen to feel sleepy or tired.

Qelbree can increase blood pressure and heart rate. Your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your child’s doctor if they show any signs of mania.

The most common side effects of Qelbree include sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability. These are not all the possible side effects of Qelbree.

You may report negative side effects to the FDA at 1-800-FDA-10881-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Medication Guide.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

Suicidal thoughts and behaviors:

  • Qelbree may increase suicidal thoughts and actions [read more] in some children with ADHD, especially within the first few months of treatment or when the dose is changed.
  • Help prevent suicidal thoughts and actions in your child or adolescent by paying close attention to any new or sudden changes in mood, behavior, thoughts, and feelings. Call your child’s doctor right away or get emergency help if there are any new or sudden changes (e.g., attempts to commit suicide, depression, agitation or restlessness, insomnia, acting aggressive, angry or violent, an extreme increase in activity and talking, thoughts about suicide or dying, anxiety, panic attacks, irritability, acting on dangerous impulses, and other unusual changes in behavior or mood).
  • Qelbree may increase suicidal thoughts and actions in some children with ADHD, especially within the first few months of treatment or when the dose is changed. [read more]
  • Help prevent suicidal thoughts and actions in your child or adolescent by paying close attention to any new or sudden changes in mood, behavior, thoughts, and feelings. Call your child’s doctor right away or get emergency help if there are any new or sudden changes (e.g., attempts to commit suicide, depression, agitation or restlessness, insomnia, acting aggressive, angry or violent, an extreme increase in activity and talking, thoughts about suicide or dying, anxiety, panic attacks, irritability, acting on dangerous impulses, and other unusual changes in behavior or mood).

Your child should not take Qelbree if they: take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or stopped taking an MAOI in the last 14 days; or take alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, or theophylline.

Tell your child’s doctor about all your child’s medical conditions, such as: a personal or family history of suicide, bipolar disorder, depression, mania or hypomania, blood pressure or heart rate problems, severe kidney or liver problems

Before taking Qelbree, tell your doctor if your child is or plans to become pregnant or, is or plans to breastfeed. You and your child’s doctor will decide if your child should take Qelbree.

Tell your doctor about all medicines your child takes or recently has taken. Qelbree and other medicines may affect each other causing possible serious side effects. Do not start or stop any medicines while taking Qelbree without talking to your child’s doctor first.

Do not let your teen drive or operate heavy machinery until you know how Qelbree will affect them. Qelbree may cause your teen to feel sleepy or tired.

Qelbree can increase blood pressure and heart rate. Your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your child’s doctor if they show any signs of mania.

The most common side effects of Qelbree include sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability. These are not all the possible side effects of Qelbree.

You may report negative side effects to the FDA at 1-800-FDA-10881-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Medication Guide.